{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:16:54Z","timestamp":1790662614654,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s40620-014-0108-6","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T12:07:26Z","timestamp":1400501246000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study"],"prefix":"10.1093","volume":"28","author":[{"given":"Chien-Te","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Shan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsiung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"108_CR1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095\u20132128","journal-title":"Lancet"},{"key":"108_CR2","unstructured":"US Renal Data System (2013) USRDS 2013 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5301\/JN.2011.8374","volume":"24","author":"ED Thodis","year":"2011","unstructured":"Thodis ED, Oreopoulos DG (2011) Home dialysis first: a new paradigm for new ESRD patients. J Nephrol 24:398\u2013404","journal-title":"J Nephrol"},{"issue":"Suppl 2","key":"108_CR4","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1681\/ASN.2005060663","volume":"16","author":"JA Coladonato","year":"2005","unstructured":"Coladonato JA (2005) Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol 16(Suppl 2):S107\u2013S114","journal-title":"J Am Soc Nephrol"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1523-1755.2004.09004.x","volume":"90","author":"WY Qunibi","year":"2004","unstructured":"Qunibi WY (2004) Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD). Kidney Int Suppl 90:S8\u2013S12","journal-title":"Kidney Int Suppl"},{"key":"108_CR6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10157-011-0461-x","volume":"15","author":"E Kusano","year":"2011","unstructured":"Kusano E (2011) Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol 15:627\u2013633","journal-title":"Clin Exp Nephrol"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11255-010-9857-x","volume":"42","author":"LM Miller","year":"2010","unstructured":"Miller LM, Sood MM, Sood AR et al (2010) Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Int Urol Nephrol 42:1007\u20131014","journal-title":"Int Urol Nephrol"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-139X.2010.00823.x","volume":"24","author":"W Qunibi","year":"2011","unstructured":"Qunibi W, Kalantar-Zadeh K (2011) Target levels for serum phosphorus and parathyroid hormone. Semin Dial 24:29\u201333","journal-title":"Semin Dial"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1525-139X.2010.00750.x","volume":"23","author":"OM Guti\u00e9rrez","year":"2010","unstructured":"Guti\u00e9rrez OM, Wolf M (2010) Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. Semin Dial 23:401\u2013406","journal-title":"Semin Dial"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","volume":"362","author":"M Tonelli","year":"2010","unstructured":"Tonelli M, Pannu N, Manns B (2010) Oral phosphate binders in patients with kidney failure. N Engl J Med 362:1312\u20131324","journal-title":"N Engl J Med"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrneph.2011.112","volume":"7","author":"AJ Hutchison","year":"2011","unstructured":"Hutchison AJ, Smith CP, Brenchley PE (2011) Pharmacology, efficacy and safety of oral phosphate binders. Nat Rev Nephrol 7:578\u2013589","journal-title":"Nat Rev Nephrol"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/17.2.265","volume":"17","author":"WC Yang","year":"2002","unstructured":"Yang WC, Yang CS, Hou CC, Wu TH, Young EW, Hsu CH (2002) An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate. Nephrol Dial Transplant 17:265\u2013270","journal-title":"Nephrol Dial Transplant"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.ajkd.2012.11.041","volume":"61","author":"JP Dwyer","year":"2013","unstructured":"Dwyer JP, Sika M, Schulman G et al (2013) Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial. Am J Kidney Dis 61:759\u2013766","journal-title":"Am J Kidney Dis"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"c25","DOI":"10.1159\/000341922","volume":"121","author":"M Sinsakul","year":"2012","unstructured":"Sinsakul M, Sika M, Koury M et al (2012) The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients. Nephron Clin Pract 121:c25\u2013c29","journal-title":"Nephron Clin Pract"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000344008","volume":"36","author":"K Yokoyama","year":"2012","unstructured":"Yokoyama K, Hirakata H, Akiba T, Sawada K, Kumagai Y (2012) Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial. Am J Nephrol 36:478\u2013487","journal-title":"Am J Nephrol"},{"key":"108_CR16","doi-asserted-by":"crossref","unstructured":"Yokoyama K, Akiba T, Fukagawa M et al (2014) A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. Nephrol Dial Transplant 29(5):1053\u20131060","DOI":"10.1093\/ndt\/gft483"},{"key":"108_CR17","unstructured":"Panion & BF Biotech, Inc. (2006) A randomized, double-blind, placebo-controlled, dose-ranging study of the effects of ferric citrate on serum phosphate in patients with end stage renal disease (ESRD). Panion & BF Biotech, Inc., Report No. PBB00101"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt JL, Lin HY (2012) Mechanisms of anemia in CKD. J Am Soc Nephrol 23:1631\u20131634","journal-title":"J Am Soc Nephrol"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/sdi.12042","volume":"26","author":"MS Calvo","year":"2013","unstructured":"Calvo MS, Uribarri J (2013) Contributions to total phosphorus intake: all sources considered. Semin Dial 26:54\u201361","journal-title":"Semin Dial"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1681\/ASN.V1061274","volume":"10","author":"CH Hsu","year":"1999","unstructured":"Hsu CH, Patel SR, Young EW (1999) New phosphate binding agents: ferric compounds. J Am Soc Nephrol 10:1274\u20131280","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"108_CR21","first-page":"279","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group (2012) KDIGO Clinical Practice Guideline for anemia in chronic kidney disease. Kidney Int 2(Suppl):279\u2013335","journal-title":"Kidney Int"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00420.x","volume":"21","author":"S Fishbane","year":"2008","unstructured":"Fishbane S (2008) Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines. Semin Dial 21:217\u2013220","journal-title":"Semin Dial"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0108-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0108-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:45Z","timestamp":1777564665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/1\/105\/8372172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0108-6","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}